Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes?
Abstract
Although type II diabetes is associated with both microvascular and macrovascular complications, duration of diabetes and severity of glycemia are strongly associated only with the former. Since prediabetic individuals are hyperinsulinemic, and since hyperinsulinemia may be a cardiovascular risk factor, we hypothesized that prediabetic individuals might have an atherogenic pattern of risk factors even before the onset of clinical diabetes, thereby explaining the relative lack of an association of macrovascular complications with either glycemic severity or disease duration. We documented the cardiovascular risk factor status of 614 initially nondiabetic Mexican Americans who later participated in an 8-year follow-up of the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease. Individuals who were nondiabetic at the time of baseline examination, but who subsequently developed type II diabetes (ie, confirmed prediabetic subjects, n = 43), had higher levels of total and lowdensity lipoprotein cholesterol, triglyceride, fasting glucose and insulin, 2-hour glucose, body mass index, and blood pressure, and lower levels of high-density lipoprotein cholesterol than subjects who remained nondiabetic (n = 571). Most of these differences persisted after adjustment for obesity and/or level of glycemia, but were abolished after adjustment for fasting insulin concentration. When subjects with impaired glucose tolerance at baseline (n = 106) were eliminated, the more atherogenic pattern of cardiovascular risk factors was still evident (and statistically significant) among initially normoglycemic prediabetic subjects. These results indicate that prediabetic subjects have an atherogenic pattern of risk factors (possibly caused by obesity, hyperglycemia, and especially hyperinsulinemia), which may be present for many years and may contribute to the risk of macrovascular disease as much as the duration of clinical diabetes itself. (JAMA. 1990;263:2893-2898)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The risk of progressing from prediabetes to overt type 2 diabetes is greatest for people with a history of gestational diabetes, a strong family history of type 2 diabetes, progressive increments in glycemia within the prediabetes range, and who meet criteria for a combination of impaired fasting glucose, impaired glucose tolerance, or metabolic syndrome (any 2 out of 3).
“The risk of progressing from prediabetes to overt T2D are greatest for those persons with a history of GDM, strong family history of T2D, progressive increments in glycemia within the prediabetes range, and who meet criteria for a combination of IFG, IGT, or metabolic syndrome (any 2 out of 3).9,805,806”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [805]
Elevated TG and insulin resistance may both impair HDL function and predate the development of diabetes.
“In this regard, elevated TG and insulin resistance may both impair HDL function37-39 and predate the development of diabetes.40”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [40]
High triglyceride levels that accompany either normal or impaired fasting glucose predict the development of T2DM.
“High triglyceride levels that accompany either normal or impaired fasting glucose predict the development of T2DM, 166,167 and therefore, hypertriglyceridemic states should prompt surveillance to rule out T2DM.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [166]
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · see citing works
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784 · see citing works
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871 · see citing works
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709 · see citing works
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624 · see citing works
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698 · see citing works
Ceriello, A., & Motz, E. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000122852.22604.78 · Cited by 1,378 · see citing works
Adipokines: molecular links between obesity and atheroslcerosis
Lau, D., Dhillon, B., Yan, H., Szmitko, P. E., & Verma, S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01058.2004 · Cited by 930 · see citing works
Freeman, D. J., Norrie, J., Sattar, N., Neely, R. D. G., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.357 · Cited by 844 · see citing works
Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds
Grundy, S. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.046 · Cited by 679 · see citing works
Salomaa, V. V., Riley, W. A., Kark, J. D., Nardo, C. J., & Folsom, A. R. (1995) · Circulation · doi:10.1161/01.cir.91.5.1432 · Cited by 580 · see citing works
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535 · see citing works
Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease
Stehouwer, C. D. A., Henry, R. M. A., & Ferreira, I. (2008) · Diabetologia · doi:10.1007/s00125-007-0918-3 · Cited by 560 · see citing works
Perry, I. J., Wannamethee, S. G., Walker, M. K., Thomson, A. G., Whincup, P. H., & Shaper, A. G. (1995) · BMJ · doi:10.1136/bmj.310.6979.560 · Cited by 532 · see citing works
The metabolic syndrome: is this diagnosis necessary?
Reaven, G. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1237 · Cited by 546 · see citing works
Adipose Tissue Macrophages Promote Myelopoiesis and Monocytosis in Obesity
Nagareddy, P. R., Kraakman, M. J., Masters, S. L., Stirzaker, R. A., Gorman, D. J., Grant, R. W., Dragoljevic, D., Hong, E. S., Abdel‐Latif, A., Smyth, S. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.029 · Cited by 510 · see citing works
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507 · see citing works
Haffner, S. M., Mykkänen, L. M., Festa, A., Burke, J. P., & D, M. P. S. M. (2000) · Circulation · doi:10.1161/01.cir.101.9.975 · Cited by 454 · see citing works
Self-citationHigh-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
Drew, B. G., Duffy, S. J., Formosa, M. F., Natoli, A. K., Henstridge, D. C., Penfold, S. A., Thomas, W. G., Mukhamedova, N., de Courten, B., Forbes, J. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843219 · Cited by 443 · see citing works
Folli, F. B., Kahn, C. R., Hansen, H. F., Bouchie, J. L., & Feener, E. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119752 · Cited by 424 · see citing works
Schofield, J. D., Liu, Y., Rao‐Balakrishna, P., Malik, R. A., & Soran, H. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0167-x · Cited by 430 · see citing works
Pathophysiology of impaired pulsatile insulin release
Bergsten, P. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200005/06)16:3 · Cited by 69 · see citing works
Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links
De Rosa, S., Arcidiacono, B., Chiefari, E., Brunetti, A., Indolfi, C., & Foti, D. P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00002 · Cited by 369 · see citing works
Stranders, I., Diamant, M., van Gelder, R. E., Spruijt, H. J., Twisk, J. W. R., Heine, R. J., & Visser, F. C. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.9.982 · Cited by 353 · see citing works
Coronary atherosclerosis in diabetes mellitus
Goraya, T., Leibson, C. L., Palumbo, P. J., Weston, S. A., Killian, J. M., Pfeifer, E. A., Jacobsen, S. J., Frye, R. L., & Roger, V. L. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02065-x · Cited by 353 · see citing works
Hawkins, B. T., Lundeen, T. F., Norwood, K., Brooks, H. L., & Egleton, R. D. (2006) · Diabetologia · doi:10.1007/s00125-006-0485-z · Cited by 348 · see citing works
Rader, D. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.003 · Cited by 345 · see citing works
The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.5.1566 · Cited by 333 · see citing works
Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 329 · see citing works
Diabetes Mellitus as a Risk Factor for Death From Stroke
Tuomilehto, J., Rastenytė, D., Jousilahti, P., Sarti, C., & Vartiainen, E. A. (1996) · Stroke · doi:10.1161/01.str.27.2.210 · Cited by 321 · see citing works
DeFronzo, R. A., & Abdul‐Ghani, M. A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.013 · Cited by 318 · see citing works
Insulin resistance is a cardiovascular risk factor in humans
Adeva‐Andany, M. M., Martínez‐Rodríguez, J., González-Lucán, M., Fernández‐Fernández, C., & Castro-Quintela, E. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.02.023 · Cited by 314 · see citing works
Durrington, P. N. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14234-1 · Cited by 311 · see citing works
The emerging role of HDL in glucose metabolism
Drew, B. G., Rye, K.-A., Duffy, S. J., Barter, P., & Kingwell, B. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.235 · Cited by 307 · see citing works
Pathophysiological implications of insulin resistance on vascular endothelial function
Wheatcroft, S. B., Williams, I. L., Shah, A. M., & Kearney, M. T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00869.x · Cited by 307 · see citing works
Insulin resistance and risk for stroke
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., & Horwitz, R. I. (2002) · Neurology · doi:10.1212/wnl.59.6.809 · Cited by 280 · see citing works
Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine
Udler, M. S., McCarthy, M. I., Florez, J. C., & Mahajan, A. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00088 · Cited by 302 · see citing works
Relation of Glycohemoglobin and Adiposity to Atherosclerosis in Youth
McGill, H. C., McMahan, C. A., Malcom, G. T., Oalmann, M. C., & Strong, J. P. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.4.431 · Cited by 296 · see citing works
Diabetes and atherosclerosis: is there a role for hyperglycemia?
Chait, A., & Bornfeldt, K. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800059-jlr200 · Cited by 292 · see citing works
Prediabetes and Cardiovascular Disease
Brannick, B., & Dagogo-Jack, S. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.001 · Cited by 293 · see citing works
Vascular dysfunction in diabetes mellitus
Feener, E. P., & King, G. L. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90022-2 · Cited by 287 · see citing works
Dietary Fat Consumption and Health
Lichtenstein, A. H., Kennedy, E., Barrier, P., Danford, D. E., Ernst, N. D., Grundy, S. M., Leveille, G. A., Horn, L. V., Williams, C. L., & Booth, S. L. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1998.tb01728.x · Cited by 289 · see citing works
Preventing Cardiovascular Disease and Diabetes
Eckel, R. H., Kahn, R., Robertson, R. M., & Rizza, R. A. (2006) · Circulation · doi:10.1161/circulationaha.106.176583 · Cited by 288 · see citing works
Prevalence of coronary artery disease in Asian Indians
Enas, E. A., Yusuf, S., & Mehta, J. L. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90744-j · Cited by 285 · see citing works
Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome
Wang, H. H., Lee, D. K., Liu, M., Portincasa, P., & Wang, D. Q. ‐. (2020) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2020.23.3.189 · Cited by 294 · see citing works
Coronary heart disease in individuals with spinal cord injury: assessment of risk factors
Bauman, W. A., & Spungen, A. M. (2008) · Spinal Cord · doi:10.1038/sj.sc.3102161 · Cited by 279 · see citing works
Insulin resistance, inflammation, and the prediabetic state
Haffner, S. M. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00612-x · Cited by 268 · see citing works
Self-citationThe epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it?
Nathan, D. M., Meigs, J. B., & Singer, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90021-0 · Cited by 264 · see citing works
Festa, A., Williams, K., Hanley, A. J., Otvos, J. D., Goff, D. C., Wagenknecht, L. E., & Haffner, S. M. (2005) · Circulation · doi:10.1161/circulationaha.104.512079 · Cited by 259 · see citing works
Self-citationImpact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
Ferrannini, E., & DeFronzo, R. A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv239 · Cited by 256 · see citing works
Bao, W., Srinivasan, S. R., & Berenson, G. S. (1996) · Circulation · doi:10.1161/01.cir.93.1.54 · Cited by 256 · see citing works
Molecular mechanisms of chromium in alleviating insulin resistance
Hua, Y., Clark, S., Ren, J. T., & Sreejayan, N. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.11.001 · Cited by 258 · see citing works
Obesity and Insulin Resistance
Després, J., & Marette, A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_4 · Cited by 254 · see citing works
Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index
Palaniappan, L. P., Wong, E. C., Shin, J., Fortmann, S. P., & Lauderdale, D. S. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.152 · Cited by 238 · see citing works
Zimmet, P., Boyko, E. J., Collier, G. R., & de Courten, M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07783.x · Cited by 233 · see citing works
Festa, A., Hanley, A. J., Tracy, R. P., D’Agostino, R., & Haffner, S. M. (2003) · Circulation · doi:10.1161/01.cir.0000091339.70120.53 · Cited by 231 · see citing works
Self-citationMetabolic Changes in Persons After Spinal Cord Injury
Bauman, W. A., & Spungen, A. M. (2000) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/s1047-9651(18)30150-5 · Cited by 229 · see citing works
Insulin Resistance Implications for Type II Diabetes Mellitus and Coronary Heart Disease
Haffner, S. M., & Miettinen, H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00027-2 · Cited by 227 · see citing works
Self-citationNorris, S. L., Kansagara, D. L., Bougatsos, C., & Fu, R. F. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00008 · Cited by 226 · see citing works
Winer, N., & Sowers, J. R. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004263017 · Cited by 224 · see citing works
Impaired glucose metabolism predicts mortality after a myocardial infarction
Bolk, J. H., van der Ploeg, T., Cornel, J. H., Arnold, A. E. R., Sepers, J. M., & Umans, V. A. W. M. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00422-3 · Cited by 215 · see citing works
Wang, Y., Liu, B., Han, H., Hu, Y., Zhu, L., Rimm, E. B., Hu, F. B., & Sun, Q. (2023) · Nutrition Journal · doi:10.1186/s12937-023-00877-2 · Cited by 220 · see citing works
The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk
Femlak, M., Gluba-Brzózka, A., Ciałkowska-Rysz, A. D., & Rysz, J. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0594-3 · Cited by 222 · see citing works
Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view
Zimmet, P., Shaw, J. E., & Alberti, K. G. M. M. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01052.x · Cited by 207 · see citing works
Mykkänen, L. M., Kuusisto, J., Pyörälà, K., & Laakso, M. (1993) · Diabetologia · doi:10.1007/bf02743273 · Cited by 206 · see citing works
Kahn, H. S., & Valdez, R. A. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.5.928 · Cited by 203 · see citing works
Mensah, G. A., Mokdad, A. H., Ford, E. S., Narayan, K. M. V., Giles, W. H., Vinicor, F., & DEEDWANIA, P. C. (2004) · Cardiology Clinics · doi:10.1016/j.ccl.2004.06.005 · Cited by 202 · see citing works
Makrilakis, K., Liatis, S., Grammatikou, S., Perrea, D., Stathi, C., Tsiligros, P., & Katsilambros, N. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.006 · Cited by 199 · see citing works
The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease
Haffner, S. M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0343 · Cited by 193 · see citing works
Self-citationDiagnosis, prevention, and intervention for the metabolic syndrome.
Scott, C. (2003) · American Journal of Cardiology · doi:10.1016/s0002-9149(03)00507-1 · Cited by 214 · see citing works
Hsueh, W. A., & Law, R. E. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.100261 · Cited by 191 · see citing works
Wabitsch, M., Hauner, H., Hertrampf, M., Muche, R., Hay, B., Mayer, H. G., Kratzer, W., Debatin, K.-M., & Heinze, E. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802555 · Cited by 188 · see citing works
Bianchi, S., Bigazzi, R., & Campese, V. M. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70002-8 · Cited by 185 · see citing works
Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology
Sowers, J. R. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.691 · Cited by 184 · see citing works
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00007 · Cited by 184 · see citing works
Osuna C., J. A., Gómez-Pérez, R., Arata-Bellabarba, G., & Villaroel, V. (2006) · Archives of Andrology · doi:10.1080/01485010600692017 · Cited by 183 · see citing works
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease
Reaven, G. M., & Laws, A. (1994) · Diabetologia · doi:10.1007/bf00400953 · Cited by 179 · see citing works
Kuller, L. H., Velentgas, P., Barzilay, J. I., Beauchamp, N. J., O’Leary, D. H., & Savage, P. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.823 · Cited by 181 · see citing works
McNeill, A. M., Rosamond, W. D., Girman, C. J., Heiss, G., Golden, S. H., Duncan, B. B., East, H. E., & Ballantyne, C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.07.107 · Cited by 177 · see citing works
The Look AHEAD Trial: a review and discussion of its outcomes
Pi-Sunyer, X. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0099-x · Cited by 176 · see citing works
The epidemiology of impaired glucose tolerance and hypertension
Kannel, W. B., Wilson, P. W. F., & Zhang, T. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90432-h · Cited by 178 · see citing works
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176 · see citing works
Schwartz, E. A., Koska, J., Mullin, M. P., Syoufi, I., Schwenke, D. C., & Reaven, P. D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.028 · Cited by 173 · see citing works
Diabetes and Progression of Carotid Atherosclerosis
Wagenknecht, L. E., Zaccaro, D. J., Espeland, M. A., Karter, A. J., O’Leary, D. H., & Haffner, S. M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000072273.67342.6d · Cited by 172 · see citing works
Self-citationThe insulin resistance syndrome: physiological considerations
Kashyap, S. R., & DeFronzo, R. A. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.001 · Cited by 172 · see citing works
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Fonseca, V. A., Desouza, C. V., Asnani, S., & Jialal, I. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0034 · Cited by 165 · see citing works
Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity
Brehm, A., Pfeiler, G., Pacini, G., Vierhapper, H., & Roden, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.037556 · Cited by 169 · see citing works
Austin, M. A., Mykkänen, L. M., Kuusisto, J., Edwards, K. L., Nelson, C., Haffner, S. M., Pyörälà, K., & Laakso, M. (1995) · Circulation · doi:10.1161/01.cir.92.7.1770 · Cited by 164 · see citing works
Self-citationLiver‐Fat Accumulation and Insulin Resistance in Obese Women with Previous Gestational Diabetes
Tiikkainen, M., Tamminen, M., Häkkinen, A., Bergholm, R., Vehkavaara, S., Halavaara, J. T., Teramo, K., Rissanen, A., & Yki‐Järvinen, H. (2002) · Obesity Research · doi:10.1038/oby.2002.118 · Cited by 161 · see citing works
Ravikumar, R., Deepa, R., Shanthirani, C. S., & Mohan, V. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02593-6 · Cited by 161 · see citing works
Evolving Trends in the Epidemiology, Risk Factors, and Prevention of Type 2 Diabetes: A Review
Weisman, A., Fazli, G. S., Johns, A., & Booth, G. L. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.03.002 · Cited by 161 · see citing works
Petersen, J. L., & McGuire, D. K. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.007 · Cited by 159 · see citing works
Diabetes mellitus, race, and socioeconomic status a population-based study
Brancati, F. L., Whelton, P. K., Kuller, L. H., & Klag, M. J. (1996) · Annals of Epidemiology · doi:10.1016/1047-2797(95)00095-x · Cited by 159 · see citing works
Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial Infarction
Levantesi, G., Macchia, A., Marfisi, R., Franzosi, M. G., Maggioni, A. P., Nicolosi, G. L., Schweiger, C., Tavazzi, L., Tognoni, G., Valagussa, F., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.062 · Cited by 157 · see citing works
Zimmet, P., & Alberti, K. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90020-9 · Cited by 156 · see citing works
The role of interleukin-18 in the metabolic syndrome
Trøseid, M., Seljeflot, I., & Arnesen, H. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-11 · Cited by 155 · see citing works
von Eckardstein, A., Schulte, H., & Assmann, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6773 · Cited by 154 · see citing works
Kreisberg, R. A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00848-0 · Cited by 154 · see citing works
Duggirala, R., Blangero, J., Almasy, L. A., Arya, R., Dyer, T. D., Williams, K. L., Leach, R. J., O'Connell, P., & D, M. P. S. M. (2001) · The American Journal of Human Genetics · doi:10.1086/320100 · Cited by 149 · see citing works
THE NATURAL HISTORY OF TYPE 2 DIABETES
Ramlo-Halsted, B. A., & Edelman, S. V. (1999) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70130-5 · Cited by 150 · see citing works
- Authors
- Haffner, S. M.
- Corresponding author
- Haffner, Steven M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1990-06-06
- Volume
- 263
- Issue
- 21
- Pages
- 2893
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4297681290
- Cited by
- 668
- References
- 0
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 14 · 2023: 9 · 2022: 18 · 2021: 12 · 2020: 23 · 2019: 15 · 2018: 16 · 2017: 14 · 2016: 17 · 2015: 25 · 2014: 21 · 2013: 16 · 2012: 22
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- prediabetes, type 2 diabetes, cardiovascular risk factors, hyperinsulinemia, atherogenic lipid profile, impaired glucose tolerance, macrovascular complications, Mexican Americans, San Antonio Heart Study, fasting insulin, obesity, disease duration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review